2/26, 11:15 PM (Source: TeleTrader)
more TeleTrader news

FDA panel recommends J&J's COVID-19 vaccine

United States Food and Drug Administration's (FDA) advisory board on Friday recommended Johnson & Johnson's single-shot coronavirus vaccine candidate for Emergency Use Authorization (EUA).

The Vaccines and Related Biological Products Advisory Committee determined that benefits outweigh the risks and endorsed the candidate's usage in adults over 18 years of age, with a 22-0 vote, paving the way for the FDA to allow distribution of the third coronavirus vaccine in the US.

The news comes on the day the nation commemorated administering its 50 millionth inoculation.

Breaking the News / NL